Microbiological and immunological diagnosis of tuberculous spondylodiscitis

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue SUPPL. 2, 2012, Pages 73-78

  Delogu, G ^a   Zumbo, A ^a   Fadda, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Pott's Disease; Spinal TB; Tuberculosis

Indexed keywords

BACTERIUM DETECTION; BACTERIUM ISOLATION; CYTOKINE RELEASE; EFFECTOR CELL; GOLD STANDARD; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; POSTPRIMARY TUBERCULOSIS; PRIMARY TUBERCULOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOUS SPONDYLITIS; DISKITIS; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INTERVERTEBRAL DISK; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; OSTEOMYELITIS; PREDICTIVE VALUE; PROGNOSIS; T LYMPHOCYTE;

BIOLOGICAL MARKER; CYTOKINE;

BACTERIOLOGICAL TECHNIQUES; BIOLOGICAL MARKERS; CYTOKINES; DISCITIS; HUMANS; IMMUNOLOGIC TECHNIQUES; INTERVERTEBRAL DISC; MYCOBACTERIUM TUBERCULOSIS; OSTEOMYELITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS, SPINAL;

EID: 84862642913     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. WORLD HEALTH ORGANIZATION. Global Tuberculosis Control. Surveillance, Planning, Financing, 2009.
2. BROSCH R, GORDON SV, MARMIESSE M, BRODIN P, BUCHRIESER C, EIGLMEIER K, GARNIER T, GUTIERREZ C, HEWINSON G, KREMER K, PARSONS LM, PYM AS, SAMPER S, VAN SOOLINGEN D, COLE ST. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002; 99: 3684-3689.
3. COLE ST, BROSCH R, PARKHILL J, GARNIER T, CHURCHER C, HARRIS D, GORDON SV, EIGLMEIER K, GAS S, BARRY CE 3RD, TEKAIA F, BADCOCK K, BASHAM D, BROWN D, CHILLINGWORTH T, CONNOR R, DAVIES R, DEVLIN K, FELTWELL T, GENTLES S, HAMLIN N, HOLROYD S, HORNSBY T, JAGELS K, KROGH A, MCLEAN J, MOULE S, MURPHY L, OLIVER K, OSBORNE J, QUAIL MA, RAJANDREAM MA, ROGERS J, RUTTER S, SEEGER K, SKELTON J, SQUARES R, SQUARES S, SULSTON JE, TAYLOR K, WHITEHEAD S, BARRELL BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [see comments] [published erratum appears in Nature 1998; 396(6707): 190]. Nature 1998; 11: 537-544.
4. COLE ST. Comparative and functional genomics of the Mycobacterium tuberculosis complex. Microbiology 2002; 148: 2928.
5. KAUFMANN SH, MCMICHAEL AJ. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 2005; 11: S33-44.
6. DELOGU G, FADDA G. The quest for a new vaccine against tuberculosis. J Infect Dev Ctries 2009; 3: 5-15.
7. BRENNAN MJ, FRUTH U, MILSTIEN J, TIERNAN R, DE ANDRADE NS, CHOCARRO L. Development of new tuberculosis vaccines: a global perspective on regulatory issues. PLoS Med 2007; 4: e252.
8. BARRY CE, III, SLAYDEN RA, SAMPSON AE, LEE RE. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem Pharmacol 2000; 59: 221-231.
9. LE PAGE L, FEYDY A, RILLARDON L, DUFOUR V, LE HÉ- NANFF A, TUBACH F, BELMATOUG N, ZARROUK V, GUIGUI P, FANTIN B. Spinal tuberculosis: a longitudinal study with clinical, laboratory, and imaging outcomes. Semin Arthritis Rheum 2006; 36: 124-129.
10. COTTLE L, RIORDAN T. Infectious spondylodiscitis. J Infect 2008; 56: 401-412.
11. KAUFMANN SH, COLE ST, MIZRAHI V, RUBIN E, NATHAN C. Mycobacterium tuberculosis and the host response. J Exp Med 2005; 201: 1693-1697.
12. RUSSELL DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 2007; 5: 39-47.
13. MITTRUCKER HW, STEINHOFF U, KOHLER A, KRAUSE M, LAZAR D, MEX P, MIEKLEY D, KAUFMANN SH. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 2007; 104: 12434-12499.
14. PETHE K, ALONSO S, BIET F, DELOGU G, BRENNAN MJ, LOCHT C, MENOZZI FD. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001; 412: 190-194.
15. DELOGU G, SANGUINETTI M, POSTERARO B, ROCCA S, ZANETTI S, FADDA G. The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice. Infect Immun 2006; 74: 3006-3011.
16. BARRY CE, III, BOSHOFF HI, DARTOIS V, DICK T, EHRT S, FLYNN J, SCHNAPPINGER D, WILKINSON RJ, YOUNG D. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7: 845-855.
17. BOSHOFF HI, BARRY CE, III. Tuberculosis- metabolism and respiration in the absence of growth. Nat Rev Microbiol 2005; 3: 70-80.
18. LAWN SD, WOOD R, WILKINSON RJ. Changing concepts of "latent tuberculosis infection" in patients living with HIV infection. Clin Dev Immunol 2011; 2011.
19. HERNANDEZ-PANDO R, JEYANATHAN M, MENGISTU G, AGUILAR D, OROZCO H, HARBOE M, ROOK GA, BJUNE G. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000; 356: 2133-2138.
20. NEYROLLES O, HERNANDEZ-PANDO R, PIETRI-ROUXEL F, FORNES P, TAILLEUX L, BARRIOS PAYAN JA, PIVERT E, BORDAT Y, AGUILAR D, PRÉVOST MC, PETIT C, GICQUEL B. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE 2006; 1: e43.
21. SHERMAN DR, GAGNEUX S. Estimating the mutation rate of Mycobacterium tuberculosis during infection. Nat Genet 2011; 43: 400-401.
22. FORD CB, LIN PL, CHASE MR, SHAH RR, IARTCHOUK O, GALAGAN J, MOHAIDEEN N, IOERGER TR, SACCHETTINI JC, LIPSITCH M, FLYNN JL, FORTUNE SM. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 2011; 43: 482-486.
23. RAFAILIDIS PI, AVRAMOPOULOS I, SAPKAS G, FALAGAS ME. Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates. J Infect 2006; 52: e35-e37.
24. KUMAR R, DAS RK, MAHAPATRA AK. Role of interferon gamma release assay in the diagnosis of Pott disease. J Neurosurg Spine 2010; 12: 462- 466.
25. DROUILLON V, DELOGU G, DETTORI G, LAGRANGE PH, BENECCHI M, HOURIEZ F, BAROLI K, ARDITO F, TORELLI R, CHEZZI C, FADDA G, HERRMANN JL. Multicenter evaluation of a transcription-reverse transcription concerted assay for rapid detection of mycobacterium tuberculosis complex in clinical specimens. J Clin Microbiol 2009; 47: 3461-3465.
26. PIERSIMONI C, BORNIGIA S, GHERARDI G. Performance of a commercial nucleic acid amplification test with extrapulmonary specimens for the diagnosis of tuberculosis. Eur J Clin Microbiol Infect Dis 2011 Jun 24.
27. LECOUVET F, IRENGE L, VANDERCAM B, NZEUSSEU A, HAMELS S, GALA JL. The etiologic diagnosis of infectious discitis is improved by amplificationbased DNA analysis. Arthritis Rheum 2004; 50: 2985-2994.
28. DIEL R, GOLETTI D, FERRARA G, BOTHAMLEY G, CIRILLO D, KAMPMANN B, LANGE C, LOSI M, MARKOVA R, MIGLIORI GB, NIENHAUS A, RUHWALD M, WAGNER D, ZELLWEGER JP, HUITRIC E, SANDGREN A, MANISSERO D. Interferon-γ release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. Eur Respir J 2011; 37: 88-89.
29. BROSCH R, GORDON SV, GARNIER T, EIGLMEIER K, FRIGUI W, VALENTI P, DOS SANTOS S, DUTHOY S, LACROIX C, GARCIA-PELAYO C, INWALD JK, GOLBY P, GARCIA JN, HEWINSON RG, BEHR MA, QUAIL MA, CHURCHER C, BARRELL BG, PARKHILL J, COLE ST. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 2007; 104: 5596-5601.
30. GOLETTI D, RAJA A, SYED AHAMED KB, RODRIGUES C, SODHA A, CARRARA S, VERNET G, LONGUET C, IPPOLITO G, THANGARAJ S, LEPORTIER M, GIRARDI E, LAGRANGE PH. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIVinfected persons? PLoS ONE 2010; 5: e12577.
31. MASUNGI C, TEMMERMAN S, VAN VOOREN JP, DROWART A, PETHE K, MENOZZI FD, LOCHT C, MASCART F. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis 2002; 185: 513-520.
32. TEMMERMAN S, PETHE K, PARRA M, ALONSO S, ROUANET C, PICKETT T, DROWART A, DEBRIE AS, DELOGU G, MENOZZI FD, SERGHERAERT C, BRENNAN MJ, MASCART F, LOCHT C. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med 2004; 10: 935-941.
33. ZANETTI S, BUA A, DELOGU G, PUSCEDDU C, MURA M, SABA F, PIRINA P, GARZELLI C, VERTUCCIO C, SECHI LA, FADDA G. Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutinin. Clin Diagn Lab Immunol 2005; 12: 1135-1138.
34. DELOGU G, BUA A, PUSCEDDU C, PARRA M, FADDA G, BRENNAN MJ, ZANETTI S. Expression and Purification of Recombinant Methylated HBHA in Mycobacterium smegmatis. FEMS Microbiol Lett 2004; 239: 33-39.
35. DELOGU G, CHIACCHIO T, VANINI V, BUTERA O, CUZZI G, BUA A, MOLICOTTI P, ZANETTI S, LAURIA FN, GRISETTI S, MAGNAVITA N, FADDA G, GIRARDI E, GOLETTI D. Methylated HBHA produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders. PLoS ONE 2011; 6: e1815.
36. CARRARA S, VINCENTI D, PETROSILLO N, AMICOSANTE M, GIRARDI E, GOLETTI D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004; 38: 754-756.